Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Acts upstream of or within tendon formation. Is expressed in several structures, including bone element; cephalic musculature; fin; myoseptum; and operculohyoid ligament. Orthologous to human SCX (scleraxis bHLH transcription factor).